A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

AIM Of the many biological targets of oxidative stress, lipids are the most involved class of biomolecules. Lipid oxidation gives rise to a number of secondary products. Malondialdehyde (MDA) is the principal and most studied product of polyunsaturated fatty acid peroxidation. This aldehyde is a highly toxic molecule and should be considered as more than just a marker of lipid peroxidation. Its interaction with DNA and proteins has often been referred to as potentially mutagenic and atherogenic. This review is intended to briefly describe the physiological origin of MDA, to highlight its toxicity, describe and comment on the most recent methods of detection and discuss its occurrence and significance in pathology. DATA SYNTHESIS In vivo origin as well as reactivity and consequent toxicity of MDA are reviewed. The most recent and improved procedures for the evaluation of MDA in biological fluids are described and discussed. The evidence of the occurrence of increased MDA levels in pathology is described. CONCLUSIONS In the assessment of MDA, the most common methods of detection are insufficiently sensitive and disturbed by interference coming from related species or overestimation derived from stressing analysis conditions. Moreover, no recent nutritional or medical trials report the use of one of the new and more reliable methods, some of which are undoubtedly accessible to virtually all the laboratories provided with a common HPLC or a spectrofluorimeter.

[1]  S. Jain,et al.  Erythrocyte Membrane Lipid Peroxidation and Glycosylated Hemoglobin in Diabetes , 1989, Diabetes.

[2]  M. Beksaç,et al.  Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. , 2001, Clinical biochemistry.

[3]  J. Steghens,et al.  Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. , 2001, Free radical biology & medicine.

[4]  Yu-jing Zhang,et al.  Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. , 2002, Carcinogenesis.

[5]  S. Shiesh,et al.  Total antioxidant capacity and malondialdehyde in acute abdominal pain. , 2002, The American journal of emergency medicine.

[6]  L. Graver,et al.  Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples. , 1997, Clinical chemistry.

[7]  N. Day,et al.  Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  S. Chirico,et al.  High-performance liquid chromatography-based thiobarbituric acid tests. , 1994, Methods in enzymology.

[9]  R. S. Sohal,et al.  Mechanisms of aging: an appraisal of the oxidative stress hypothesis. , 2002, Free radical biology & medicine.

[10]  J. Vertommen,et al.  Oxidative stress status in patients with diabetes mellitus: relationship to diet , 2003, European Journal of Clinical Nutrition.

[11]  S. Manoharan,et al.  Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[12]  K. G. Akbulut,et al.  Daily variations of plasma malondialdehyde levels in patients with early breast cancer. , 2003, Cancer detection and prevention.

[13]  B. Halliwell,et al.  Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. , 1993, Free radical research communications.

[14]  L. Marnett Lipid peroxidation-DNA damage by malondialdehyde. , 1999, Mutation research.

[15]  J. Nielsen,et al.  Plasma malondialdehyde as biomarker for oxidative stress : reference interval and effects of life-style factors , 1996 .

[16]  C. Stalikas,et al.  Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry. , 2001, Analytical biochemistry.

[17]  P. Elsner,et al.  Oxidative stress in malignant melanoma and non‐melanoma skin cancer , 2003, The British journal of dermatology.

[18]  E. Frankel,et al.  Formation of malonaldehyde from lipid oxidation products , 1983 .

[19]  R. Ferrari,et al.  Oxidative stress in cardiovascular disease: myth or fact? , 2003, Archives of biochemistry and biophysics.

[20]  P. Mecocci,et al.  Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. , 2002, Free radical biology & medicine.

[21]  I. Young,et al.  Measurement of Malondialdehyde in Plasma by High Performance Liquid Chromatography with Fluorimetric Detection , 1991, Annals of clinical biochemistry.

[22]  L. Marnett,et al.  Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry. , 2003, Analytical biochemistry.

[23]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  N. Pellegrini,et al.  Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. , 2003, Clinical chemistry.

[25]  J. Isenberg,et al.  Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[26]  Manfred S. Green,et al.  Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  D. Naidoo,et al.  Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  C. Exley,et al.  Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  H. Maral,et al.  Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. , 2002, Clinical biochemistry.

[30]  K. Uchida Role of reactive aldehyde in cardiovascular diseases. , 2000, Free radical biology & medicine.

[31]  S. Auriola,et al.  Mass spectrometric (HPLC/ESI--MS/MS) quantification of pyrimido[1,3-a]purin-10(3H)-one, a guanine adduct formed by reaction of malondialdehyde with DNA. , 1999, Journal of pharmaceutical and biomedical analysis.

[32]  D. Slatter,et al.  The importance of lipid-derived malondialdehyde in diabetes mellitus , 2000, Diabetologia.

[33]  Y. Ozkan,et al.  Plasma malondialdehyde (MDA) levels in breast and lung cancer patients , 2001, Journal of clinical pharmacy and therapeutics.

[34]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[35]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[36]  M. Boaz,et al.  Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. , 1999, Kidney international.

[37]  D. Ferguson,et al.  Analysis of the malondialdehyde-2'-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. , 1997, Chemical research in toxicology.

[38]  T. Yoshioka,et al.  Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. , 1979, American journal of obstetrics and gynecology.

[39]  Shawn D. Chase,et al.  Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  N. Sucu,et al.  Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. , 2002, Archives of medical research.

[41]  A. Espinosa-Mansilla,et al.  Kinetic behaviour of the malonaldehyde-thiobarbituric acid reaction. kinetic-fluorimetric determination of malonaldehyde in human serum , 1996 .

[42]  J. Dyr,et al.  Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[43]  N. Ilhan,et al.  The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia. , 2002, Clinical biochemistry.

[44]  J. Langridge,et al.  Mass spectrometric analysis of 2-deoxyribonucleoside and 2'-deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation. , 1998, Rapid communications in mass spectrometry : RCM.

[45]  R. Paroni,et al.  Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. , 2002, Clinical chemistry.

[46]  Naim Uzun,et al.  Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[47]  L. Marnett,et al.  Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Paroni,et al.  Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. , 1999, Analytical biochemistry.

[49]  R. Bird,et al.  Comparative studies on different methods of malonaldehyde determination. , 1984, Methods in enzymology.

[50]  K. G. Akbulut,et al.  Differential Effects of Pharmacological Doses of Melatonin on Malondialdehyde and Glutathione Levels in Young and Old Rats , 1999, Gerontology.

[51]  W. Pryor,et al.  Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. , 1975, The Journal of organic chemistry.

[52]  L. Marnett,et al.  Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay. , 1998, Carcinogenesis.

[53]  M. Hecker,et al.  On the mechanism of prostacyclin and thromboxane A2 biosynthesis. , 1989, The Journal of biological chemistry.

[54]  J. Čermák,et al.  Solid-phase extraction in malondialdehyde analysis. , 1997, Analytical biochemistry.

[55]  K. Yoneyama,et al.  Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[56]  J. Arnaud,et al.  Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. , 1991, Nephron.

[57]  A. Carrascosa,et al.  Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. , 2003, Free radical biology & medicine.

[58]  Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978 .

[59]  K. Torén,et al.  Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[60]  J. Knight,et al.  Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. , 1988, Clinical chemistry.

[61]  A. Federico,et al.  Oxidative stress in viral and alcoholic hepatitis. , 2003, Free radical biology & medicine.

[62]  M. Raftery,et al.  Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[63]  A. Zhitkovich,et al.  Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. , 1999, Mutation research.

[64]  L. Marnett,et al.  Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human Cells* , 2003, Journal of Biological Chemistry.

[65]  Wei-Chang Tseng,et al.  Determination of Thiobarbituric Acid Adduct of Malondialdehyde Using On-line Microdialys is Coupled with High-Performance Liquid Chromatography , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[66]  N. Delibaş,et al.  Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. , 2002, Clinical biochemistry.

[67]  J. Kalaivani Sailaja,et al.  Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. , 2002, Clinical biochemistry.

[68]  L. Marnett,et al.  Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA. , 2002, Chemical research in toxicology.

[69]  D. Doerge,et al.  An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues. , 1998, Chemical research in toxicology.

[70]  F. Karatas,et al.  Determination of free malondialdehyde in human serum by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[71]  W. Wąsowicz,et al.  Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. , 1993, Clinical chemistry.

[72]  S. Taysı,et al.  Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. , 2002, Japanese journal of clinical oncology.